75N95024F00001↗

Booz Allen Hamilton Inc received this contract from National Institutes of Health Nida, National Institutes of Health: $9.80M obligated so far for health r&d services; health care services; basic research. Its period of performance ended 2025-09-16.

Key facts · data as of Oct 26, 2026

Recipient
Booz Allen Hamilton Inc
Awarding agency
National Institutes of Health (Department of Health and Human Services)
Contracting office
National Institutes of Health Nida (75N950)
Obligated to date
$9.80M
Potential value
$9.80M
Ends
2025-09-16

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.

Cite this page: SpendQuery, Award 75N95024F00001, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75N95024F00001_7529_75N95021D00023_7529

FY24 AWARD. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2024 - SEPTEMBER 16, 2025. N01DA-21-5588. TASK ORDER 75N95024F00001 (TO4).

Delivery Order · National Institutes of Health · to Booz Allen Hamilton Inc (UEI JCBMLGPE6Z71) · data as of 2026-10-26

Obligated to date$9.80M2 actions
Current value$9.80Mwith options exercised
Period2024-09-17 → 2025-09-16current end date
Passed on$8.36Mto 3 subcontractors

What it is

Product or service
Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry
Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office
National Institutes of Health Nida (75N950)
Competition
Full and open competition
Pricing
Firm fixed price
How it was bought
Single-award IDIQ · under 75N95021D00023
Solicitation
75N95024F00001
Where the work is
Fairfax, VA · district VA-11

Obligations by fiscal year

FY2024$9.80M
FY2026-$165

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

3 subawards totaling $8.36M (85.3% of what was obligated), as Booz Allen Hamilton Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.

SubcontractorAmountSubawardsWhereFirstLast
Infinity Biologix LLC$6.65M1NJ2024-11-222024-11-22
United States Drug Testing Laboratories, Inc.$1.67M1IL2024-11-062024-11-06
Four Points Technology, L.L.C.$35.6K1VA2024-12-232024-12-23
The largest single subawards
DateToAmountFor
2024-11-22Infinity Biologix LLC$6.65MSAMPLE BIOSTORAGE AND LAB SERVICES
2024-11-06United States Drug Testing Laboratories, Inc.$1.67MTOXICOLOGICAL ANALYSIS OF BIOLOGICAL TISSUES AND FLUIDS
2024-12-23Four Points Technology, L.L.C.$35.6KIT VAR THAT RESELLS IT PRODUCTS AND SERVICES TO THE FEDERAL GOVERNMENT.

Every action

2 actions since 2024-09-11. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-05-14P00001Funding only-$165FY26 UDO INITIATIVE. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2024 - SEPTEMBER 16, 2025. N01DA-21-5588. TASK ORDER 75N95024F00001 (TO4).
2024-09-110$9.80MFY24 AWARD. NIDA DEVELOPMENTAL STUDIES BIOREPOSITORY AND ANALYSIS CENTER. SEPTEMBER 17, 2024 - SEPTEMBER 16, 2025. N01DA-21-5588. TASK ORDER 75N95024F00001 (TO4).

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗